M

Minerva Neurosciences

11 employees

Minerva Neurosciences focuses on the development and commercialization of a portfolio of product candidates to treat CNS diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Central Nervous System Disorders
Neuroscience
Biopharma
Negative Symptoms
Major Depressive Disorder
Parkinson's Disease
Health Care
Schizophrenia
Insomnia

Date founded

2007

Funding rounds raised

Total raised

$31M

from 6 investors over 6 rounds

M

Minerva Neurosciences raised $4.2M on September 2, 2017

Investors: Sphera Fund

M

Minerva Neurosciences raised $31M on March 24, 2015

Investors: HCP Ltd, Index Ventures, DAFNA Capital Management, LLC and Perceptive Advisors

M

Minerva Neurosciences raised $15M on January 20, 2015

Investors: Oxford Finance LLC

FAQ